Current Setup & Catalysts
Current Setup in One Page
The stock is trading around $42.10, sitting $2.10 above the $40 ceiling of the $200M modified Dutch Auction tender authorized March 2026 — the market has effectively pre-priced full subscription at the cap. The setup is mixed: the capital-return story has over-delivered (sale-leaseback closed for $400M+ net, balance sheet flipped to net cash, $300M repurchase authorization within 90 days), while the operating story is unfinished (Adjusted EBITDA guide cut from $160–170M to $146–156M, Education Solutions in its third "reposition" in five years, $25M of YTD FY26 "one-time" addbacks vs $10.1M a year ago). The next six months are dominated by two hard-dated events: the tender close (summer 2026) and the FY2026 10-K (late July 2026) — the latter carries the live 9 Story goodwill impairment test, the FY26 final addback total, and the first read on tariff pass-through inside Children's. The underwriting case turns on the 10-K disclosures and the CEO succession decision tied to Warwick's July 2026 rolling-contract renewal.
Recent Setup Rating
Hard-dated events (6 mo)
High-impact catalysts
Days to next hard date
The single highest-impact near-term event is the FY2026 10-K (expected late July 2026). Three disclosures converge in one filing: the 9 Story Entertainment goodwill impairment test on $336.5M of carrying value, the final FY26 "one-time" addback total (already $25M YTD vs $10.1M prior YTD, +148% YoY), and the CEO contract status on Warwick's July 2026 rolling-contract anniversary. The Dutch tender close is the bigger short-term mechanical event but the smaller thesis update.
What Changed in the Last 3-6 Months
Narrative arc, 6 months in one paragraph. Six months ago the debate was whether SCHL was a value-trap publisher dragging through the ESSER cliff with too much real estate. Today the sale-leaseback has monetized the real estate at a premium, the buyback program is funded for the next 12 months, and Children's has continued to print 12–14% margins through tariff pressure. The argument now is whether the FY26 10-K validates the per-share compounding case (no impairment, lower addback) or reframes it from "cheap because misunderstood" to "cheap because earnings power is $55M, not $145M." The unresolved question: are the "one-time" addbacks ending in FY26, or is FY26 the third year of an institutionalized $20–30M cost classification?
What the Market Is Watching Now
The live debate is not whether Scholastic is generating cash — it is. The debate is whether the cash is being generated by the business (Children's franchise + International stabilization + Education transformation) or by the balance sheet (sale-leaseback proceeds, working-capital releases, addback presentation). The next two filings (tender close + FY26 10-K) frame that question for the next 12 months.
Ranked Catalyst Timeline
The FY26 10-K is the only filing on the calendar that could move all three legs of the underwriting debate at once. The Dutch tender is mechanically bigger but thesis-narrower; the governance events (CEO contract, proxy) are spread out and only one — succession — has decision-relevant content. Consensus estimates for FY26 / FY27 EPS, revenue, and EBITDA were not available in the staged data; rely on management's own guide ($146-$156M Adj EBITDA, ~flat revenue, FCF >$430M including sale-leaseback proceeds) until consensus reads are refreshed.
Impact Matrix
The matrix is deliberately concentrated: the FY26 10-K and the Dutch tender close together account for the bulk of the next-six-month decision value. The other items modulate, but do not replace, what the July 2026 filing will say.
Next 90 Days
The 90-day calendar is dense in late July: tender close, Q4 FY26 / FY26 release, FY26 10-K, and CEO contract renewal can plausibly all land in the same week. Most of the next-12-month re-underwriting work resolves in that single window.
What Would Change the View
Three observables would most change the investment debate: (1) the FY26 10-K language on Children's segment Q4 margin combined with the 9 Story goodwill impairment outcome — together they speak to Long-Term Thesis row 1 (school-channel franchise durability) and Failure Mode 5 (9 Story as cap-allocation discipline test); (2) the CEO contract renewal decision in July 2026 — the cleanest tell on whether the controlling-shareholder structure remains disciplined or consolidates into a Lucchese-as-CEO seat that could redirect capital toward Entertainment empire-building; and (3) the Dutch tender insider-participation disclosure in the Schedule 13E-4 — the first observable own-view signal on the controlling holder's behavior at the $40 price cap, against an internal forensic ledger that flags zero open-market insider buying in the last 30 Form 4 filings. Favorable resolution on all three (margin in band, no impairment, external CEO search, modest controlling-holder tender) keeps the SOTP framework intact and extends the per-share compounding case. Unfavorable resolution (margin breaks the band, material impairment, internal Lucchese elevation, controlling-holder block tender at $40) crystallizes the bear thesis inside one filing window, making the discount-to-peer multiple the correct one rather than a mispricing.